文献速递瓣膜外科

全内镜下主动脉瓣与二尖瓣置换术中自动化瓣环缝合装置的首次应用经验

First experiences with automated annular suturing device in totally endoscopic aortic and mitral valve replacement.
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2024-01-01

本研究在德国2个心脏外科转诊中心纳入2020年9月至2023年6月连续66例(平均年龄61.8±11岁)经右前小切口行全内镜下主动脉瓣或二尖瓣置换术的患者,所有患者均使用RAM®装置。结果显示体外循环时间97.9±20.9分钟、主动脉阻断时间66±15.7分钟,ICU停留1[1-2]天、住院9[7-13]天,无瓣周漏及术中并发症,30天及院内死亡均为零,1例(1.5%)因出血转为胸骨切开。作者认为该装置安全、可行且有效,但需更大样本研究评估其疗效与安全性。

要点

  • 66例全内镜下主动脉瓣或二尖瓣置换术均使用RAM®装置,30天及院内死亡均为零。
  • 无瓣周漏及术中并发症,1例(1.5%)因出血转为胸骨切开。
  • 体外循环时间97.9±20.9分钟,主动脉阻断时间66±15.7分钟,住院9[7-13]天。

核心结论

  • 作者认为RAM®装置用于内镜下主动脉瓣或二尖瓣植入安全、可行且有效,早期结果优良,但需更大样本研究评估其疗效与安全性。

研究设计与样本

  • 2020年9月至2023年6月在德国2个心脏外科转诊中心连续纳入66例(平均年龄61.8±11岁)经右前小切口行全内镜下主动脉瓣或二尖瓣置换术的患者,所有患者均使用RAM®装置,临床数据前瞻性录入机构数据库。

主要发现

  • 体外循环时间97.9±20.9分钟,主动脉阻断时间66±15.7分钟,ICU停留1[1-2]天,住院9[7-13]天。
  • 无瓣周漏及其他术中并发症,30天及院内死亡均为零。
  • 1例(1.5%)患者因出血转为胸骨切开。
  • RAM®装置3.5号与5.0号分别用于16.7%和83.3%的患者。
  • 主动脉瓣、二尖瓣及双瓣手术分别占81.8%、15.2%和1.5%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者指出需要更大样本的研究来评估RAM®装置的疗效与安全性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To overcome some of the challenges of endoscopic minimally invasive valve surgery, an automated annular suturing device has been used in aortic and mitral valve replacement surgeries. The current study investigates early clinical outcomes of patients who received aortic or mitral valve replacement with the help of the RAM® device as first experiences in minimally invasive valve surgery. METHODS: Between September 2020 and June 2023, 66 consecutive patients (mean age 61.8 ± 11 years) underwent endoscopic minimally invasive aortic or mitral valve replacement through right anterior mini-thoracotomy at 2 cardiac surgery referral centres in Germany. The RAM® device was used in all Patients. 3.5 and 5.0 sizes were used in 16.7% and 83.3% of patients, respectively. Aortic, mitral and double valve surgery was performed in 81.8%, 15.2% and 1.5% of patients, respectively. Clinical data were prospectively entered into our institutional database. RESULTS: Cardiopulmonary bypass time and cross-clamping time were 97.9 ± 20.9 and 66 ± 15.7 min, respectively. Intensive care unit and hospital stays were 1 [1-2] and 9 [7-13] days, respectively. No paravalvular leak and no other intraoperative complications occurred. 30-day and in-hospital mortality were zero. Conversion to sternotomy occurred in 1 (1.5%) patient due to bleeding. CONCLUSIONS: The usage of the RAM® device is a safe, feasible and effective approach to the endoscopic implantation of aortic or mitral valves and yield excellent early outcomes. Larger size studies are needed to evaluate the efficacy and safety of RAM® device.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. El-Sayed Ahmad A, Salamate S, Granov N, et al. First experiences with automated annular suturing device in totally endoscopic aortic and mitral valve replacement. Interdiscip Cardiovasc Thorac Surg. 2024. PMID: 38830025. doi:10.1093/icvts/ivae112

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。